Clinical Trials Logo

Cerebral Palsy clinical trials

View clinical trials related to Cerebral Palsy.

Filter by:

NCT ID: NCT03117322 Completed - Cerebral Palsy Clinical Trials

Synbiotic, Prebiotics and Probiotics in Children With Cerebral Palsy and Constipation

Start date: June 5, 2017
Phase: Phase 4
Study type: Interventional

Randomized double blind controlled clinical trial. Participants will be enrolled at the New Civil Hospital of Guadalajara "Dr. Juan I. Menchaca" during the period from May 2017 to July 2018, from six to 59 months of either sex. The duration of each participant in the study will be of four weeks. Each participant will be randomized assigned to any of the different study groups: synbiotic, prebiotic, probiotic or placebo. Hypothesis: The efficacy of supplementation with a symbiotic, a prebiotic and a probiotic differs in its beneficial effect on the intestinal microbiota and the characteristics of feces in children with CP and chronic constipation.

NCT ID: NCT03112434 Completed - Clinical trials for Unilateral Spastic Cerebral Palsy

Muscle Elastography in Spastic Cerebral Palsy

Start date: December 14, 2017
Phase:
Study type: Observational

To date, clinical tests are unable to differentiate between the cause of muscle stiffness, although a manual instrumented spasticity assessment for the lower limb that utilizes surface electromyogram has recently been proposed. This study intends to use shear wave elastography to assess individual muscle stiffness parameters and the individual response to botulinum toxin injection in the elbow and wrist flexors. Collection of baseline spasticity parameters could then be used to predict the effect of botulinum toxin type A and ultimately serve as a basis for development of a treatment model for muscle spasticity in patients with spastic cerebral palsy.

NCT ID: NCT03099993 Completed - Clinical trials for Unilateral Cerebral Palsy

Sensitivity of an Upper Limb Motion Analysis Protocol to Changes in Kinematics and Muscle Activity After Constraint Induced Therapy in Children With Hemiplegia

MouvsupTCIHemi
Start date: March 28, 2017
Phase: N/A
Study type: Interventional

In France, Cerebral Palsy (CP) affects 1 in 450 births. It results from lesions of the brain, before, during, or shortly after birth. These non-progressive lesions cause muscle impairments, responsible for activity limitations. These muscle impairments include muscle stiffness, and muscle weakness. Children with Unilateral CP (UCP) have these impairments on only one side of the body. To compensate for activity limitations with their impaired arm, these children over-use their non-impaired arm. The objective of constraint-induced therapy (CIT) is to minimize this asymmetry which deteriorates mobility on the impaired side, by forcing the child to only use its impaired arm several hours a day during several weeks of therapy. It is known using clinical tests that this therapy improves the overall motor function of the impaired arm. However, the underlying mechanisms are yet unknown. An understanding of these mechanisms would suggest ways to maximize the effectiveness of this therapy, which requires a significant commitment from the child and its family. The investigaors propose in this project a quantitative and objective evaluation of the effect of CIT on the movements of the impaired arm of children with UCP. The investogators focus their analysis on muscle activation, to assess which aspect of muscle impairments is modified by CIT. To this end, the investigators will use sensors identical to those already used in clinics for the Quantified Gait Analysis of children with CP, recognized since 2006 by the Haute Autorité de Santé as providing key supplementary data in the evaluation of complex gait disorders. Results from this study will provide leads to optimize CIT. Some children could for example benefit from CIT paired with treatments to reduce muscle stiffness or to strengthen muscles

NCT ID: NCT03094455 Completed - Hemiplegia Clinical Trials

AOT and ICT for Hemiplegia

Tele-UPCAT
Start date: March 29, 2017
Phase: N/A
Study type: Interventional

A new rehabilitative approach, called AOT, based on the recent discovery of mirror neuron system (MNS), has been used with promising results on the Upper Limb (UL) function in some studies in children with Cerebral Palsy (CP).The purpose of the present trial is to provide evidence by a RCT that AOT is an effective rehabilitation tool in Children with Unilateral CP (UCP) and that its effects are greater than standard care. Assisting Hand Assessment is chosen as primary outcome measure and a sample size of 10 per group is required. The rehabilitation lasting 3 weeks will be provided at home by an ICT platform able to deliver, manage, monitor and measure a personalized AOT.

NCT ID: NCT03087110 Completed - Cerebral Palsy Clinical Trials

Stem Cells in Umbilical Blood Infusion for CP

SCUBI-CP
Start date: March 2016
Phase: Phase 1
Study type: Interventional

This study will investigate the safety of single dose intravenous infusion of cord blood cells which were cryopreserved after the birth of a brother or sister to a child with cerebral palsy.

NCT ID: NCT03079362 Completed - Cerebral Palsy Clinical Trials

SDR Monitoring in Children With Cerebral Palsy

Start date: January 15, 2007
Phase: N/A
Study type: Observational

The study evaluates the anatomical distribution of the assessed Electromyogram (EMG) responses ensuring after sensory nerve root stimulation and obtained IOM grading during selective dorsal rhizotomy (SDR) with regard to level and, side of the body and gender as well as pain management and outcome data.

NCT ID: NCT03059342 Completed - Cerebral Palsy Clinical Trials

Functional Follow-up After Single Event Multilevel Surgery in Children Spastic Diplegic Cerebral Palsy

Start date: December 3, 2012
Phase:
Study type: Observational

Purpose: The aim of this study is to assess the short- and midterm evolution of self-care and functional mobility after multilevel surgery in children and adolescents with spastic diplegic cerebral palsy and to identify which factors could have an impact on these outcomes. Methods: Thirty-four participants were included. All participants will be evaluated before surgery, at 9 weeks, 6,12,18, 24, 36 and 60 months. Self-care was assessed with the Pediatric Evaluation of Disability Inventory-NL (PEDI-NL). The Mobility Questionnaire47 (MobQues47) and Functional Mobility Scale (FMS) were used to measure functional mobility. Interactions between CP, personal and environmental characteristics and evolution in time were assessed.

NCT ID: NCT03054441 Completed - Hemiplegia Clinical Trials

Actigraphs for Detection of Asymmetries

Start date: January 2017
Phase:
Study type: Observational [Patient Registry]

In hemiplegia quantitatively measurement of the asymmetry in the use of upper limbs could overcome the limitation of many outcome measures in which scores are dependent on the experience and training of the therapist. The main aim of this study was to determine the validity of Actigraph GXT3+ to measure asymmetry in the use of the two upper limbs during the Assisting Hand Assessment (AHA) in children, adolescents and young with hemiplegia aged 5-19 years, compared to age-matched typically developing subjects (TD).

NCT ID: NCT03048851 Completed - Cerebral Palsy Clinical Trials

Efficacy of New Protocols in the Treatment of Upper Limb Dysfunctions in Patients With Cerebral Palsy

Start date: August 2015
Phase: N/A
Study type: Interventional

Immediate and maintaining Efficacy of new protocols in the treatment of upper limb dysfunctions in patients with cerebral palsy.

NCT ID: NCT03041818 Completed - Cerebral Palsy Clinical Trials

Development of Horse-Riding Program Model for Children With Cerebral Palsy

Start date: March 14, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to develop healing riding algorithm applicable in rural riding centers and to apply this to children with cerebral palsy.